Because both substances impact blood sugar and digestion, the additive effect is the primary concern for clinicians
Individual results may differ based on dose tolerance, health history, nutrition, activity, treatment adherence, and other factors
Jonathan Shults with Coastal Empire Orthopedics provides a medically supervised weight loss program
Discuss your medication with your anaesthetist and surgical team, as local policies may vary and individual assessment is essential
Wider access to GLP-1 medicines (glucagon-like peptide-1) for obesity and diabetes will help reduce the burden of these conditions.''Winselow Tucker, president and GM, Eli Lilly and Co (India) said: "India is entering a transformative phase in obesity and chronic weight-management care, driven by a rising disease burden, greater recognition of obesity as a chronic disease, and broader access to evidence-based prescription therapies